Berlin, Germany

Gabriele Schumann-Giampieri

This inventor holds 1 USPTO granted patent. Top assignee: Schering Aktiengesellschaft. Active years: 2001.


% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2001

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Gabriele Schumann-Giampieri: Innovator in Cascade Polymer Technology

Introduction

Gabriele Schumann-Giampieri is a notable inventor based in Berlin, Germany. He has made significant contributions to the field of polymer chemistry, particularly in the development of complexing compounds. His innovative work has implications for both diagnostics and therapeutic applications.

Latest Patents

Gabriele Schumann-Giampieri holds a patent for "Cascade polymer bound complexing compounds, their complexes and conjugates, processes for their production, and pharmaceutical agents containing them." This patent describes cascade polymers that contain complex-forming ligands and can include various ions and cations. These compounds are valuable for their ability to form complexes that can be utilized in medical diagnostics and therapies.

Career Highlights

Throughout his career, Schumann-Giampieri has been associated with Schering Aktiengesellschaft, a prominent pharmaceutical company. His work has focused on the intersection of polymer science and medicine, leading to advancements that enhance the efficacy of pharmaceutical agents.

Collaborations

He has collaborated with esteemed colleagues such as Heinz Gries and Heribert Schmitt-Willich. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas in the field of polymer chemistry.

Conclusion

Gabriele Schumann-Giampieri's contributions to cascade polymer technology exemplify the impact of innovative thinking in the pharmaceutical industry. His work continues to influence the development of complexing compounds that hold promise for future medical applications.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…